NUNZIA PHARMACEUTICAL COMPANY
CIK 0000886093
Revenue (TTM)
$0
Q3 Nov 2022
Net Income (TTM)
−$19.01M
+22.7% YoY
Q3 Nov 2022
EPS Diluted (TTM)
−$0.04
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
—
Q3 Nov 2022
Net Margin
—
Q3 Nov 2022
Free Cash Flow (TTM)
—
Q3 Nov 2022
Cash
$131
Q3 Nov 2022
Total Debt
$0
Q3 Nov 2022
Shares Outstanding
434.51M sh
Q3 Nov 2022
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.